Potentially malignant disorders
Leukoplakia and erythroplakia are clinical terms after excluding other causes. Histology, site and appearance inform risk and surveillance.
Understand
Oral potentially malignant disorders vary in transformation risk; appearance, site, dysplasia and patient factors all matter. Histology samples only the tissue submitted.
Assess
Examine the entire mouth and neck, photograph and map lesions, and compare previous records. Note homogeneous versus non-homogeneous change and focal areas for biopsy.
Apply
Agree risk modification, biopsy or specialist referral and a surveillance plan. Any new ulceration, induration or rapid change warrants reassessment before the planned interval.
Key distinctions
Risk of transformation is not uniform within a diagnosis such as leukoplakia. Non-homogeneous appearance, erythroplakia, site, size and dysplasia can raise concern, but no single reassuring feature guarantees safety. Surveillance includes patient education, tobacco and alcohol support, documented baseline and a mechanism to investigate change between scheduled reviews.
Think through a case
A leukoplakia biopsy shows no dysplasia, but a focal red area later develops. The changing clinical picture warrants a new assessment despite the previous result.
The distinction to remember
Do not treat a negative sample as lifelong clearance of the whole lesion.
Test your recall
Does a benign-looking white patch remove the need for review?
Show answer
No; evolution and clinicopathological correlation matter.